IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
IDEXX Laboratories (IDXX) PT Raised to $530 at BTIG
February 3, 2025 3:56 PM ESTBTIG analyst Mark Massaro raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $530.00 (from $500.00) while maintaining a Buy rating.
The analyst comments "Despite ongoing challenges related to pet visits, IDXX delivered a solid beat on the top and bottom line in... More
IDEXX Laboratories (IDXX) PT Raised to $460 at Stifel
February 3, 2025 12:16 PM ESTStifel analyst Jonathan D. Block raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $460.00 (from $440.00) while maintaining a Hold rating.
The analyst comments "IDEXX delivered a good quarterits first revenue beat since 4Q23leading to a big move in the stock... More



